A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
oping a bridging therapy suitable for treating large numbers of people exposed to high doses of ionizing irradiation. These preclinical experiments indicate that allogeneic MP generated from purified HSC by ex vivo expansion can function as a bridging therapy during hematopoietic recovery following high-dose radiation. [Abstract Withdrawn] 169doi:10.1016/j.bbmt.2004.12.171 fatcat:pv2bmxulvzgvjpcaeyh73kg6xi